42318 Federal Register / Vol. 83, No. 162 / Tuesday, August 21, 2018 / Notices 

contained therein, is available for 

inspection during official business 

hours (8:45 a.m. to 5:15 p.m.) in the 

Office of the Secretary, U.S. 

International Trade Commission, 500 E 

Street SW, Room 112, Washington, DC 

20436, telephone (202) 205–2000. 

Hearing impaired individuals are 

advised that information on this matter 

can be obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. Persons with mobility 

impairments who will need special 

assistance in gaining access to the 

Commission should contact the Office 

of the Secretary at (202) 205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server at https://

www.usitc.gov. The public record for 

this investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Katherine Hiner, The Office of the 

Secretary, Docket Services, U.S. 

International Trade Commission, 

telephone (202) 205–1802. 

SUPPLEMENTARY INFORMATION: 

Authority: The authority for 

institution of this investigation is 

contained in section 337 of the Tariff 

Act of 1930, as amended, 19 U.S.C. 

1337, and in section 210.10 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10 (2018). 

Scope of Investigation: Having 

considered the amended complaint, the 

U.S. International Trade Commission, 

on August 15, 2018, ordered that— 

(1) Pursuant to subsection (b) of 

section 337 of the Tariff Act of 1930, as 

amended, an investigation be instituted 

to determine whether there is a 

violation of subsection (a)(1)(B) of 

section 337 in the importation into the 

United States, the sale for importation, 

or the sale within the United States after 

importation of products identified in 

paragraph (2) by reason of infringement 

of one or more of claims 1–10, 12, 16, 

17, 19–28, and 30–42 of the ’407 patent 

and claims 1–9, 11, 13, 14, 17–22 and 

24–29 of the ’058 patent; and whether 

an industry in the United States exists 

as required by subsection (a)(2) of 

section 337; 

(2) Pursuant to section 210.10(b)(1) of 

the Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10(b)(1), the 

plain language description of the 

accused products or category of accused 

products, which defines the scope of the 

investigation, is ‘‘lithography machines 

that use projection objectives to project 

circuit patterns drawn on a ‘mask’ or 

‘reticle’ onto a photoresist on a silicon 

wafer, components of the lithography 

machines, and systems related to the 

operation of the lithography machines’’; 

(3) For the purpose of the 

investigation so instituted, the following 

are hereby named as parties upon which 

this notice of investigation shall be 

served: 

(a) The complainants are: Carl Zeiss 

SMT GmbH, Carl-Zeiss-Strabe 22, 

Oberkochen, Germany 73447. 

(b) The respondents are the following 

entities alleged to be in violation of 

section 337, and are the parties upon 

which the amended complaint is to be 

served: 

Nikon Corporation, Shingawa Intercity 

Tower C, 2–15–3 Konan, Minato-ku, 

Tokyo 108–6290, Japan. 

Nikon Research Corporation of America, 

1399 Shoreway Road, Belmont, CA 

94002–4107. 

Nikon Precision Inc., 1399 Shoreway 

Road, Belmont, CA 94002. 

(4) For the investigation so instituted, 

the Chief Administrative Law Judge, 

U.S. International Trade Commission, 

shall designate the presiding 

Administrative Law Judge. 

The Office of Unfair Import 

Investigations will not participate as a 

party in this investigation. 

The Chief Administrative Law Judge 

is authorized to consolidate Inv. No. 

337–TA–1128 with Inv. No. 337–TA– 

1129 if he deems it appropriate. 

Responses to the amended complaint 

and the notice of investigation must be 

submitted by the named respondents in 

accordance with section 210.13 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.13. Pursuant to 

19 CFR 201.16(e) and 210.13(a), such 

responses will be considered by the 

Commission if received not later than 20 

days after the date of service by the 

Commission of the amended complaint 

and the notice of investigation. 

Extensions of time for submitting 

responses to the amended complaint 

and the notice of investigation will not 

be granted unless good cause therefor is 

shown. 

Failure of a respondent to file a timely 

response to each allegation in the 

amended complaint and in this notice 

may be deemed to constitute a waiver of 

the right to appear and contest the 

allegations of the amended complaint 

and this notice, and to authorize the 

administrative law judge and the 

Commission, without further notice to 

the respondent, to find the facts to be as 

alleged in the amended complaint and 

this notice and to enter an initial 

determination and a final determination 

containing such findings, and may 

result in the issuance of an exclusion 

order or a cease and desist order or both 

directed against the respondent. 

By order of the Commission. 

Issued: August 15, 2018. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2018–17950 Filed 8–20–18; 8:45 am] 

BILLING CODE 7020–02–P 

EXECUTIVE OFFICE OF THE 

PRESIDENT 

OFFICE OF NATIONAL DRUG 

CONTROL POLICY 

Appointment of Members of Senior 

Executive Service Performance Review 

Board 

AGENCY: Office of National Drug Control 

Policy (ONDCP), Executive Office of the 

President. 

ACTION: Notice of Appointments. 

SUMMARY: The following persons have 

been appointed to the ONDCP Senior 

Executive Service Performance Review 

Board: Martha Gagne (as Chair), Michael 

Gottlieb, James Olson, and Kemp 

Chester. 

FOR FURTHER INFORMATION CONTACT: 

Michael Passante, Deputy General 

Counsel, (202) 395–6709, Office of 

National Drug Control Policy, Executive 

Office of the President, 750 17th Street 

NW, Washington, DC 20503. 

Dated: August 16, 2018. 

Michael Passante, 

Deputy General Counsel. 

[FR Doc. 2018–18022 Filed 8–20–18; 8:45 am] 

BILLING CODE 3280–F5–P 

NATIONAL SCIENCE FOUNDATION 

Sunshine Act Meetings 

The National Science Board, pursuant 

to NSF regulations (45 CFR part 614), 

the National Science Foundation Act, as 

amended (42 U.S.C. 1862n–5), and the 

Government in the Sunshine Act (5 

U.S.C. 552b), hereby gives notice of the 

scheduling of a teleconference for the 

transaction of National Science Board 

business, as follows: 

TIME AND DATE: Closed teleconference of 

the Committee on Oversight of the 

National Science Board, to be held 

Monday, August 27, 2018 from 4:00 

p.m. to 4:30 p.m. EDT. 

PLACE: This meeting will be held by 

teleconference at the National Science 

Foundation, 2415 Eisenhower Avenue, 

Alexandria, VA 22314. 

STATUS: Closed. 

MATTERS TO BE CONSIDERED: Chair’s 

opening remarks; discussion of FY 2020 

OIG budget request. 


sradovich on DSK3GMQ082PROD with NOTICES